These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31054506)

  • 21. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts.
    Park HJ; Son HJ; Sul OJ; Suh JH; Choi HS
    Biochem Pharmacol; 2018 May; 151():9-17. PubMed ID: 29458048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with curcumin alleviates sublesional bone loss following spinal cord injury in rats.
    Yang X; He B; Liu P; Yan L; Yang M; Li D
    Eur J Pharmacol; 2015 Oct; 765():209-16. PubMed ID: 26300394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between fluoride exposure and osteoclast markers during RANKL-induced osteoclast differentiation.
    Junrui P; Bingyun L; Yanhui G; Xu J; Darko GM; Dianjun S
    Environ Toxicol Pharmacol; 2016 Sep; 46():241-245. PubMed ID: 27500448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desoxyrhapontigenin inhibits RANKL‑induced osteoclast formation and prevents inflammation‑mediated bone loss.
    Tran PT; Park DH; Kim O; Kwon SH; Min BS; Lee JH
    Int J Mol Med; 2018 Jul; 42(1):569-578. PubMed ID: 29693149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Antiosteoporosis Effects of Zhuanggu Guanjie Pill
    Chai LJ; Zhang Y; Zhang PY; Bi YN; Yuan XM; Li YH; Wang YY; Song L; Sun LK; Zhou K
    Biomed Res Int; 2018; 2018():9075318. PubMed ID: 30345311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
    Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
    PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo.
    Tran PT; Dang NH; Kim O; Van Cuong P; Dat NT; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Jun; 59():152908. PubMed ID: 30981187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo.
    Hwang YH; Kim KJ; Kim SJ; Mun SK; Hong SG; Son YJ; Yee ST
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury.
    Li D; Lin Z; Meng Q; Wang K; Wu J; Yan H
    Eur J Pharmacol; 2017 Aug; 809():13-19. PubMed ID: 28479140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo.
    Baek JM; Kim JY; Yoon KH; Oh J; Lee MS
    Int J Biol Sci; 2016; 12(5):478-88. PubMed ID: 27019631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
    Shu G; Yamamoto K; Nagashima M
    Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
    Weir EC; Lowik CW; Paliwal I; Insogna KL
    J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethanolic extract of Schizonepeta tenuifolia attenuates osteoclast formation and activation in vitro and protects against lipopolysaccharide-induced bone loss in vivo.
    Kim JY; Baek JM; Ahn SJ; Cheon YH; Park SH; Yang M; Choi MK; Oh J
    BMC Complement Altern Med; 2016 Aug; 16(1):301. PubMed ID: 27550314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Puerarin Prevents LPS-Induced Osteoclast Formation and Bone Loss via Inhibition of Akt Activation.
    Zhang Y; Yan M; Yu QF; Yang PF; Zhang HD; Sun YH; Zhang ZF; Gao YF
    Biol Pharm Bull; 2016; 39(12):2028-2035. PubMed ID: 27904045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tyrosine kinase inhibitor GNF-2 suppresses osteoclast formation and activity.
    Kim HJ; Yoon HJ; Choi JY; Lee IK; Kim SY
    J Leukoc Biol; 2014 Feb; 95(2):337-45. PubMed ID: 24130113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendrobium moniliforme Exerts Inhibitory Effects on Both Receptor Activator of Nuclear Factor Kappa-B Ligand-Mediated Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Bone Erosion in Vivo.
    Baek JM; Kim JY; Ahn SJ; Cheon YH; Yang M; Oh J; Choi MK
    Molecules; 2016 Mar; 21(3):295. PubMed ID: 26938522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.